Side-by-side comparison of AI visibility scores, market position, and capabilities
British consumer health company with £14B revenue; Lysol, Mucinex, Nurofen, and Durex brands managing Mead Johnson infant formula litigation while competing with P&G and J&J.
Reckitt is a British multinational consumer health and hygiene company producing market-leading brands including Nurofen (ibuprofen), Strepsils, Dettol, Lysol, Durex, Mucinex, Enfamil infant formula, and Woolite — competing across OTC health, hygiene and home, and nutrition categories. Listed on the London Stock Exchange (LSE: RKT) and headquartered in Slough, England, Reckitt generates approximately £14 billion ($17 billion) in annual revenue. The company has undergone significant portfolio reshaping, divesting its Infant Formula & Child Nutrition (IFCN) business in some markets and selling Mead Johnson Nutrition operations.\n\nReckitt's business is organized into two segments: Health (Nurofen, Strepsils, Gaviscon, Mucinex, DayQuil/NyQuil in North America) and Hygiene and Home (Lysol/Dettol disinfectants, Finish dishwasher tablets, Vanish stain remover, Air Wick). The Health segment benefits from strong brand equity in OTC medications that command premium pricing. The Hygiene segment's Lysol brand benefited significantly from COVID-19 disinfectant demand and has sustained elevated brand awareness post-pandemic.\n\nIn 2025, Reckitt faces ongoing challenges from its $2.4 billion acquisition of Mead Johnson (Enfamil) — the company has faced significant litigation related to NEC (necrotizing enterocolitis) lawsuits claiming preterm infant formula contributed to infant deaths, resulting in large court judgments against Reckitt in 2024. The company is managing these legal liabilities while continuing to run its core consumer health and hygiene portfolio. Reckitt competes with Procter & Gamble, Johnson & Johnson, and Haleon for OTC health and hygiene market share. The 2025 strategy focuses on its Power Brands in health and hygiene, cost efficiency, and resolving the Mead Johnson litigation exposure.
Hunt Valley MD global flavor leader (NYSE: MKC) at $6.72B FY2024 sales (+1%); McCormick/Old Bay/Frank's RedHot/French's brands, B2B Flavor Solutions for McDonald's and KFC, 2025 guidance 0-2% growth vs. Kraft Heinz.
McCormick & Company, Incorporated is a Hunt Valley, Maryland-based global leader in flavor — publicly traded on the New York Stock Exchange (NYSE: MKC for voting shares, MKC.V for non-voting shares) as an S&P 500 Consumer Staples component — manufacturing, marketing, and distributing spices, seasoning mixes, condiments, hot sauces, and flavor solutions under the McCormick, Lawry's, Old Bay, French's, Frank's RedHot, Stubb's, Club House, Kamis, and dozens of other branded and private label names through approximately 12,000 employees in 160 countries. In fiscal year 2024 (ending November 2024), McCormick reported net sales of $6.72 billion (+1%), adjusted EPS of $2.95, and a return to volume-led growth after two years of volume softness as consumers adjusted to post-pandemic spice price increases. For fiscal year 2025, McCormick guided 0-2% net sales growth and adjusted EPS of $3.03-$3.08, reflecting a cautious but positive outlook as consumer spending on branded flavor products stabilizes. CEO Brendan Foley, who assumed the role in 2023 (with founder-family member Lawrence Kurzius transitioning to Executive Chairman), focuses McCormick's strategy on global flavor leadership across two segments: Consumer (branded retail spices, seasonings, condiments — approximately 58% of revenue) and Flavor Solutions (B2B flavoring for foodservice chains and food manufacturing — approximately 42% of revenue). McCormick's B2B Flavor Solutions segment supplies the proprietary flavor packets and seasoning mixes used in fast food chains (McDonald's dipping sauces, KFC's Original Recipe flavor system) under undisclosed relationships that are embedded in customers' core product recipes.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.